| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 78.16B | 74.23B | 62.79B | 65.90B | 65.90B |
| Gross Profit | 24.34B | 22.31B | 19.13B | 20.05B | 21.54B |
| EBITDA | 9.72B | 8.55B | 7.55B | 10.17B | 12.00B |
| Net Income | 3.98B | 3.54B | 4.67B | 6.65B | 7.66B |
Balance Sheet | |||||
| Total Assets | 142.57B | 139.34B | 135.02B | 139.37B | 135.61B |
| Cash, Cash Equivalents and Short-Term Investments | 18.30B | 15.84B | 15.17B | 45.60B | 47.03B |
| Total Debt | 14.26B | 14.50B | 10.44B | 921.00M | 1.03B |
| Total Liabilities | 41.46B | 41.90B | 36.19B | 27.77B | 27.21B |
| Stockholders Equity | 99.25B | 95.67B | 97.17B | 110.01B | 106.82B |
Cash Flow | |||||
| Free Cash Flow | 3.73B | 3.62B | -684.00M | 3.81B | 7.78B |
| Operating Cash Flow | 7.99B | 6.21B | 1.10B | 4.95B | 8.79B |
| Investing Cash Flow | -4.33B | -3.40B | -6.93B | -3.17B | -2.32B |
| Financing Cash Flow | -4.63B | -2.38B | -24.41B | -4.23B | -6.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥778.29B | 13.21 | 18.72% | 2.94% | -0.25% | 6.57% | |
73 Outperform | ¥44.09B | 14.50 | ― | 3.74% | 4.73% | 17.55% | |
68 Neutral | ¥72.96B | 17.87 | ― | 3.27% | 5.30% | 15.22% | |
68 Neutral | ¥125.21B | 10.56 | 12.89% | 3.40% | 3.44% | -2.97% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥494.95B | 61.22 | 1.44% | 4.80% | 0.40% | 306.94% | |
55 Neutral | ¥99.91B | 40.41 | ― | 3.53% | -3.19% | -4.14% |